Moderna, Gavi cancel COVID-19 vaccine orders for rest of 2022 due to 'sufficient supply'
marketwatch.com
news
2022-10-17 10:13:24

Moderna Inc. MRNA, -0.53% said it and GAVI, the Vaccine Alliance supplying vaccines to low- and middle-income countries, have agreed to cancel remaining orders under their 2022 COVID-19 vaccine agreement given "sufficient supply." The biotechnology company has supplied Gavi with nearly 70 million doses of COVID-19 vaccines, in addition to facilitating the donation of more than 100 million doses. Moderna and Gavi said they will create a new framework that enables Gavi to buy up to 100 million COVID-19 vaccine doses in 2023.
